SBIR Topic 412: VivoSense Cancer Health Informatics Platform, Phase I

SBIR 主题 412：VivoSense 癌症健康信息学平台，第一阶段

• 批准号: 10265750
• 负责人: Kate Lyden
• 金额: $ 39.25万
• 依托单位: VIVOSENSE, INC.
• 依托单位国家: 美国
• 财政年份: 2020
• 资助国家: 美国
• 起止时间: 2020-09-16 至 2021-06-15
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10265750
• 关键词: Antineoplastic Agents; Computer software; Data; Decentralization; Devices; Disease Progression; Early Diagnosis; Goals; Informatics; Malignant Neoplasms; Patients; Phase; Physiologic Monitoring; Public Health Informatics; Small Business Innovation Research Grant; Technology; Testing; advanced analytics; anticancer research; cancer care; computerized data processing; data streams; design; graphical user interface; prototype; treatment planning; wearable sensor technology

The overarching goal of Vivonoetics, Inc. is to develop a scalable informatics platform to conduct advanced physiological monitoring and processing of data from wearable sensors. The proposed software will perform advanced analytics for early detection, continuous assessment of disease progression and treatment sideeffects, patient centric treatment plans and decentralized data capture in cancer drug trials. In this Phase I feasibility project, Vivonoetics, Inc. will engage experts in the fields of cancer research and care to conceptualize, design and build a working prototype.

Vivonotics，Inc.的首要目标是开发一个可扩展的信息学平台，以进行高级 来自可穿戴传感器的生理监测和数据处理。建议的软件将执行 用于早期发现、持续评估疾病进展和治疗副作用的高级分析， 癌症药物试验中以患者为中心的治疗计划和分散的数据捕获。在此阶段I 可行性项目，Vivonotics，Inc.将聘请癌症研究和护理领域的专家 概念化、设计和构建工作原型。